Research Report University Hospital for clinical assessment PUMA-NER-1301

Abstract

A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting

Keywords

• HER2+ Metastatic Breast Cancer
• Neratinib
• Capecitabin
• Lapatinib